Bronchial Diseases  >>  Pulmicort Turbuhaler (budesonide dry-powder inhaler)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
NCT01218399: Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations

Completed
N/A
10
US
Symbicort, Budesonide
Stanford University, AstraZeneca
Asthma
07/10
07/10
PEACE-Peds, NCT01203904: Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation

Completed
N/A
301
Japan
AstraZeneca
Bronchial Asthma
09/15
09/15

Download Options